Press releases
- More than 100 Biopharmas Increase Impactful Engagement with Veeva CRM Events Management
- Veeva Announces Fourth Quarter and Fiscal Year 2023 Results
- Industrywide Survey Reveals Centralizing Regulatory is Number One Priority for Medtech
- Six of the Top 20 Pharma Select Veeva Vault EDC as Company Standard for New Trials
- Modular Content Powers Omnichannel Engagement at Speed and Scale
- Veeva to Release Fiscal 2023 Fourth Quarter and Full Year Results on March 1, 2023
- Global CDMO Adare Pharma Solutions Harmonizing Quality with Veeva Vault Quality Suite
- Veeva Statement in Support of Proposed FTC Rule to Ban Non-Competes
- Veeva to Present at the 41st Annual J.P. Morgan Healthcare Conference
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 155.69m |
Free float | 135.38m |
P/E (TTM) | 54.01 |
Market cap | 28.61bn USD |
EPS (TTM) | 3.40 USD |
--
More ▼